» Articles » PMID: 36936787

Designing Supramolecular Self-assembly Nanomaterials As Stimuli-responsive Drug Delivery Platforms for Cancer Therapy

Overview
Journal iScience
Publisher Cell Press
Date 2023 Mar 20
PMID 36936787
Authors
Affiliations
Soon will be listed here.
Abstract

Stimuli-responsive nanomaterials have attracted substantial interest in cancer therapy, as they hold promise to deliver anticancer agents to tumor sites in a precise and on-demand manner. Interestingly, supramolecular chemistry is a burgeoning discipline that entails the reversible bonding between components at the molecular and nanoscale levels, and the recent advances in this area offer the possibility to design nanotherapeutics with improved controllability and functionality for cancer therapy. Herein, we provide a comprehensive summary of typical non-covalent interaction modes, which primarily include hydrophobic interaction, hydrogel bonding, host-guest interaction, π-π stacking, and electrostatic interaction. Special emphasis is placed on the implications of these interaction modes to design novel stimuli-responsive drug delivery principles and concepts, aiming to enhance the spatial, temporal, and dosage precision of drug delivery to cancer cells. Finally, future perspectives are discussed to highlight current challenges and future opportunities in self-assembly-based stimuli-responsive drug delivery nanotechnologies for cancer therapy.

Citing Articles

How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery? A Comprehensive Review of the Literature.

Nsairat H, Lafi Z, Al-Najjar B, Al-Samydai A, Saqallah F, El-Tanani M Int J Nanomedicine. 2025; 20:2133-2161.

PMID: 39990285 PMC: 11847455. DOI: 10.2147/IJN.S490444.


Ferritin-Based Supramolecular Assembly Drug Delivery System for Aminated Fullerene Derivatives to Enhance Tumor-Targeted Therapy.

Zhang B, Yang L, Jin Y, Lu Y, Li J, Tang G Adv Sci (Weinh). 2024; 12(8):e2413389.

PMID: 39737845 PMC: 11848615. DOI: 10.1002/advs.202413389.


Metal-organic frameworks as nanoplatforms for combination therapy in cancer treatment.

Lafi Z, Matalqah S, Abu-Saleem E, Asha N, Mhaidat H, Asha S Med Oncol. 2024; 42(1):26.

PMID: 39653960 DOI: 10.1007/s12032-024-02567-3.


Assembling a new generation of radiopharmaceuticals with supramolecular theranostics.

Moreno-Alcantar G, Drexler M, Casini A Nat Rev Chem. 2024; 8(12):893-914.

PMID: 39468298 DOI: 10.1038/s41570-024-00657-4.


Hyaluronic Acid in Nanopharmaceuticals: An Overview.

Matalqah S, Lafi Z, Yousef Asha S Curr Issues Mol Biol. 2024; 46(9):10444-10461.

PMID: 39329973 PMC: 11431703. DOI: 10.3390/cimb46090621.


References
1.
Huo M, Wang L, Wang Y, Chen Y, Shi J . Nanocatalytic Tumor Therapy by Single-Atom Catalysts. ACS Nano. 2019; 13(2):2643-2653. DOI: 10.1021/acsnano.9b00457. View

2.
Moulton B, Zaworotko M . From molecules to crystal engineering: supramolecular isomerism and polymorphism in network solids. Chem Rev. 2001; 101(6):1629-58. DOI: 10.1021/cr9900432. View

3.
Li J, Yu X, Jiang Y, He S, Zhang Y, Luo Y . Second Near-Infrared Photothermal Semiconducting Polymer Nanoadjuvant for Enhanced Cancer Immunotherapy. Adv Mater. 2020; 33(4):e2003458. DOI: 10.1002/adma.202003458. View

4.
de Lazaro I, Mooney D . Obstacles and opportunities in a forward vision for cancer nanomedicine. Nat Mater. 2021; 20(11):1469-1479. DOI: 10.1038/s41563-021-01047-7. View

5.
Guo Z, Lin L, Hao K, Wang D, Liu F, Sun P . Helix Self-Assembly Behavior of Amino Acid-Modified Camptothecin Prodrugs and Its Antitumor Effect. ACS Appl Mater Interfaces. 2020; 12(6):7466-7476. DOI: 10.1021/acsami.9b21311. View